US Stock MarketDetailed Quotes

MNOV MediciNova

Watchlist

2.380
+0.310+14.98%

Close Dec 2 16:00 ET

2.360
-0.020-0.84%

Post 19:46 ET

116.73MMarket Cap-11333P/E (TTM)

MediciNova Stock Forum

WeiTheSaint469

Nov 20 13:27

looks good!

$MediciNova (MNOV.US)$

WeiTheSaint469

Nov 20 09:55

small shares but long

$MediciNova (MNOV.US)$

Share Your Profit/Loss

Jaguar8

Nov 14 19:52

Why on watchlist? Received Notice of Allowance

$MediciNova (MNOV.US)$

Stock_Drift

Nov 14 18:01

After Hours Ticks. 7:00pm

$Mercurity Fintech (MFH.US)$ $Freightos (CRGO.US)$ $1847 Holdings (EFSH.US)$ $MediciNova (MNOV.US)$ $Despegar.com (DESP.US)$ $NextPlat (NXPL.US)$ $Legacy Education (LGCY.US)$ $Gain Therapeutics (GANX.US)$ $Red Cat Holdings (RCAT.US)$ $Siyata Mobile (SYTA.US)$ $Innovation Beverage Group (IBG.US)$ $Greenidge Generation (GREE.US)$ $The Arena Group (AREN.US)$
📊⚡️📊

Trytosaveabit

Nov 14 17:07

Update

$MediciNova (MNOV.US)$ Reuters· 6 mins ago
MediciNova Inc - Patent Is Expected to Expire No Earlier Than May 26, 2042

Jaguar8

Nov 14 17:00

NEWS

$MediciNova (MNOV.US)$
MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Covering MN-001 for Triglyceride Synthesis in the Liver

Jaguar8

Nov 11 21:17

On my watchlist tomorrow

$MediciNova (MNOV.US)$

Jaguar8

Nov 11 17:11

NEWS

$MediciNova (MNOV.US)$
MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis
MediciNova (NASDAQ: MNOV) announced it will receive monetary damages following the settlement of Sanofi-Novartis litigation. The company plans to use this non-dilutive fundingto support ongoing clinical development programs, particularly focusing on their late-stage pipeline targeting inflammatory, metabolic, and neurodegenerative diseases. The settlement validates MediciNova's in...